|
|
Volumn 34, Issue 1, 2002, Pages 69-70
|
|
Prevention of cytomegalovirus disease after heart transplantation: Preemptive therapy with 7 days' intravenous ganciclovir
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
GANCICLOVIR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
STEROID;
TACROLIMUS;
ADULT;
AGED;
ARTICLE;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG EFFECT;
FEMALE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
MAJOR CLINICAL STUDY;
MALE;
NEOPLASM;
OPPORTUNISTIC INFECTION;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TREATMENT OUTCOME;
VASCULAR DISEASE;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
GANCICLOVIR;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TIME FACTORS;
|
|
EID: 0036223885
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02669-0 Document Type: Article |
|
Times cited : (8)
|
|
References (11)
|
